Evidence map›Paper›PMID 21559363›Full record

ArticlePloS one2011

TIEG1/KLF10 modulates Runx2 expression and activity in osteoblasts.

John R Hawse, Muzaffer Cicek, Sarah B Grygo, Elizabeth S Bruinsma, Nalini M Rajamannan, Andre J van Wijnen, Jane B Lian, Gary S Stein, Merry Jo Oursler, Malayannan Subramaniam and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. KLF transcription factors in bone diseases.Journal of cellular and molecular medicine · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Kruppel-like Factors in Skeletal Physiology and Pathologies.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. GATA4 Directly RegulatesJBMR plus · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

John R HawseDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America. hawse.john@mayo.edu
Muzaffer Cicek
Sarah B Grygo
Elizabeth S Bruinsma
Nalini M Rajamannan
Andre J van Wijnen
Jane B Lian
Gary S Stein
Merry Jo Oursler
Malayannan Subramaniam
Thomas C Spelsberg
Mayo Clinic · USUniversity of Massachusetts Chan Medical School · USMayo Clinic in Arizona · USMayo Clinic in Florida · USNorthwestern University · US

Funding

CONTROL OF OSTEOBLAST PROLIFERATION AND DIFFERENTIATIONR01AR039588 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B., STEIN, GARY S. · 1990 to 2019
$8.0M
Molecular Control of Bone FormationR01AR049069 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WESTENDORF, JENNIFER J · 2003 to 2021
$5.8M
Synthesis of Osteocalcin in BoneR37DE012528 · NIDCR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B. · 2008 to 2017
$5.0M
Role of a TGF-? Regulated Gene in Human and Mouse Osteoblasts and SkeletonR01DE014036 · NIDCR · MAYO CLINIC ROCHESTER · PI HAWSE, JOHN R., SUBRAMANIAM, MALAYANNAN · 2001 to 2016
$4.7M
Role of Lrp5/Beta-Catenin in Aortic Valve CalcificationR01HL085591 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RAJAMANNAN, NALINI M · 2007 to 2011
$2.1M
ROLE OF TGF-B INDUCIBLE EARLY GENE IN OSTEOCLASTOGENESISR01AR052004 · NIAMS · MAYO CLINIC ROCHESTER · PI OURSLER, MERRY JO · 2006 to 2010
$1.6M
Role of aTGF-beta Regulated Gene in human and mouse osteoblasts and skeletonR56DE014036 · NIDCR · MAYO CLINIC ROCHESTER · PI SPELSBERG, THOMAS C · 2007 to 2007
$352k
NHLBI NIH HHS R01 HL085591NIAMS NIH HHS AR52004NIAMS NIH HHS R01 AR039588NIAMS NIH HHS R01 AR049069NIAMS NIH HHS R01 AR052004NIDCR NIH HHS DE14036NIDCR NIH HHS R01 DE014036NIDCR NIH HHS R37 DE012528NIDCR NIH HHS R56 DE014036
6 · The paper itself

Abstract

Deletion of TIEG1/KLF10 in mice results in a gender specific osteopenic skeletal phenotype with significant defects in both cortical and trabecular bone, which are observed only in female animals. Calvarial osteoblasts isolated from TIEG1 knockout (KO) mice display reduced expression levels of multiple bone related genes, including Runx2, and exhibit significant delays in their mineralization rates relative to wildtype controls. These data suggest that TIEG1 plays an important role in regulating Runx2 expression in bone and that decreased Runx2 expression in TIEG1 KO mice is in part responsible for the observed osteopenic phenotype. In this manuscript, data is presented demonstrating that over-expression of TIEG1 results in increased expression of Runx2 while repression of TIEG1 results in suppression of Runx2. Transient transfection and chromatin immunoprecipitation assays reveal that TIEG1 directly binds to and activates the Runx2 promoter. The zinc finger containing domain of TIEG1 is necessary for this regulation supporting that activation occurs through direct DNA binding. A role for the ubiquitin/proteasome pathway in fine tuning the regulation of Runx2 expression by TIEG1 is also implicated in this study. Additionally, the regulation of Runx2 expression by cytokines such as TGFβ1 and BMP2 is shown to be inhibited in the absence of TIEG1. Co-immunoprecipitation and co-localization assays indicate that TIEG1 protein associates with Runx2 protein resulting in co-activation of Runx2 transcriptional activity. Lastly, Runx2 adenoviral infection of TIEG1 KO calvarial osteoblasts leads to increased expression of Runx2 and enhancement of their ability to differentiate and mineralize in culture. Taken together, these data implicate an important role for TIEG1 in regulating the expression and activity of Runx2 in osteoblasts and suggest that decreased expression of Runx2 in TIEG1 KO mice contributes to the observed osteopenic bone phenotype.

Indexed as

Gene Expression RegulationGene Expression Regulation, NeoplasticAnimalsBase SequenceCell Line, TumorCore Binding Factor Alpha 1 SubunitDNADNA-Binding ProteinsEarly Growth Response Transcription FactorsFemaleHumansKruppel-Like Transcription FactorsMiceMice, KnockoutMolecular Sequence DataOsteoblastsCore Binding Factor Alpha 1 SubunitDNADNA-Binding ProteinsEarly Growth Response Transcription FactorsKLF10 protein, humanKLF10 protein, mouseKruppel-Like Transcription FactorsRUNX2 protein, humanRunx2 protein, mouseTranscription FactorsTransforming Growth Factor beta1

Identifiers

PMID21559363
PMCPMC3084845
OpenAlexW1968721537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.